DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts By Test Type and Country." report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific Cancer tissue diagnostics market is expected to reach US$ 730.09 Mn in 2027 from US$ 410.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.

The growth of the cancer tissue diagnostics market during the forecast period is primarily attributed to factors like the rising number of cancer patients in the Asia Pacific and technological advancements and product launches in Asian Countries. On the other hand, the emerging countries in the Asia Pacific region are expected to have opportunities for growth of the Asia Pacific cancer tissue diagnostics market in the coming years.

The Asia Pacific region follows most of the global trends for common cancer types and has some key differences. For instance, in Asia, the most common type of cancer in men is lung cancer, while in the West, it is prostate cancer. Also, in Asian females, breast cancer is the most common type of cancer. However, cervical and liver cancers occur more frequently in other regions.

Thus the growing prevalence of cancer is likely to demand new diagnostics techniques, which will drive the growth of the cancer tissue diagnostics market during the forecast period.

Asia Pacific cancer tissue diagnostics market is segmented into test type. Based on the test type, the cancer tissue diagnostics market is categorized as immunohistochemical tests and in situ hybridization tests. The immunohistochemical tests market held the largest share in 2018 and is also expected to witness rapid growth during the forecast period.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer tissue diagnostics market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cancer tissue diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Asia Pacific Cancer Tissue Diagnostics Market - Key Takeaways

3. Asia Pacific Cancer Tissue Diagnostics Market - Market Landscape

3.1 Overview

3.2 Market Segmentation

3.2.1 Asia Pacific Cancer Tissue Diagnostics Market - By Test Type

3.2.2 Asia Pacific Cancer Tissue Diagnostics Market - By Country

3.3 PEST Analysis

3.4 Expert Opinions

4. Asia Pacific Cancer Tissue Diagnostics Market-Key Market Dynamics

4.1 Key Market Drivers

4.1.1 Rising Number of Cancer Patients In Asia Pacific

4.1.2 Technological Advancements and Product Launches in Asian Countries

4.2 Key Market Restraints

4.2.1 Lack Of Resources and Awareness For Cancer Screening And Treatment in Poor/ Less Developed Countries

4.3 Key Market Opportunities

4.3.1 Emerging Countries in Asia Pacific Region

4.4 Future Trends

4.4.1 Growing Trend of Personalized Medicine

4.5 Impact Analysis Of Drivers And Restraints

5. Cancer Tissue Diagnostics Market - Asia Pacific Analysis

5.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis

5.2 Performance of Key Players

6. Asia Pacific Cancer Tissue Diagnostics Market Analysis- by Test Type

6.1 Overview

6.2 Asia Pacific Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)

6.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Type Of Fitting (Us$ Mn)

6.4 Immunohistochemical Tests Market

6.4.1 Overview

6.4.2 Asia Pacific Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)

6.4.3 Breast Cancer Market

6.4.4 Colorectal Cancer Market

6.4.5 Prostate Cancer Market

6.4.6 Stomach Cancer Market

6.4.7 Others Market

6.5 In Situ Hybridization Tests Market

6.5.3 Breast Cancer Market

6.5.4 Lung Cancer Market

6.5.5 Bladder Cancer Market

6.5.6 Others Market

7. Asia Pacific Cancer Tissue Diagnostics Market

7.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027

7.1.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

7.1.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

8. Cancer Tissue Diagnostics Market- Industry Landscape

8.1 Overview

8.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019

8.3 Organic Growth Strategies

8.3.1 Overview

8.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

8.4.1 Product Launches

8.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market

8.4.2 Product Approvals

8.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market

8.4.3 Expansion & Other Activities

8.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

8.4.4 Product Enhancements

8.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

8.5 Inorganic Growth Strategies

8.5.1 Overview

8.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

8.6.1 Agreements

8.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market

8.6.2 Partnerships & Collaborations

8.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

8.6.3 Acquisitions

8.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

9. Cancer Tissue Diagnostics Market-Key Company Profiles

9.1 Bio-Rad Laboratories, Inc.

9.2 Thermo Fisher Scientific, Inc.

9.3 F. Hoffmann-La Roche Ltd.

9.4 Abbott

9.5 Enzo Biochem Inc.

9.6 Agilent Technologies, Inc.

9.7 Cancer Genetics Inc.

9.8 Merck Kgaa (Sigma-Aldrich)

9.9 Abcam Plc.

9.10 Danaher

For more information about this report visit https://www.researchandmarkets.com/r/w917dt

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900